Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reliability and Validity of Urdu Version of Global Physical Activity Questionnaire (GPAQ-U)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04862988
Recruitment Status : Completed
First Posted : April 28, 2021
Last Update Posted : September 14, 2021
Sponsor:
Information provided by (Responsible Party):
Riphah International University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The GPAQ questionnaire is used to measure the physical activity. In this study, Investigators will observe the reliability and validity of global physical activity questionnaire in Urdu language in Pakistan among students to assess physical activity.

Condition or disease
Physical Activity

Detailed Description:

The aim of study is to translate and culturally adapt Global physical Activity Questionnaire (GPAQ) into Urdu language and secondly to investigate the reliability and validity of GPAQ in Pakistan among university students. This study will be cross sectional survey study in which convenience sampling technique will be used.

The results of study will help to know the validity and reliability of GPAQ in Urdu version among students in Pakistan. The reliability of the questionnaire will be checked through internal consistency and test-retest methods. Internal consistency will be analyzed with Cronbach's alpha value. Test-retest reliability will be assessed using an intra-class correlation coefficient with 100 patients

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Reliability and Validity of Urdu Version of Global Physical Activity Questionnaire (GPAQ-U)
Actual Study Start Date : March 15, 2021
Actual Primary Completion Date : May 30, 2021
Actual Study Completion Date : September 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Global Physical Activity Questionnaire (GPAQ) [ Time Frame: 1st day ]
    A measuring instrument to evaluate the duration of vigorous and moderate physical activities that are performed in daily living routine. Each object has a specific code starting from P1 to P16 and then activity is calculated in MET value. For Work and Recreational domains, Moderate MET value is 4.0 and Vigorous MET value is 8.0 while for Transport domains MET value is 4.0

  2. Global Physical Activity Questionnaire (GPAQ) [ Time Frame: 2nd day ]
    A measuring instrument to evaluate the duration of vigorous and moderate physical activities that are performed in daily living routine. Each object has a specific code starting from P1 to P16 and then activity is calculated in MET value. For Work and Recreational domains, Moderate MET value is 4.0 and Vigorous MET value is 8.0 while for Transport domains MET value is 4.0


Secondary Outcome Measures :
  1. International Physical Activity Questionnaire (IPAQ) [ Time Frame: 1st day ]

    A questionnaire for the assessment of population surveillance of physical activity among the adults having age(15-69).

    Expressed as MET-minutes per week: MET level x minutes of activity/day x days per week



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 69 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Students, because they are usually engaged in their studies and have no enough time to do any physical activity resulting in decline in their overall health status.
Criteria

Inclusion Criteria:

- Male and female aged over 18 years Pakistani national and native Urdu speakers Able to read and understand Urdu Studying in University level

Exclusion Criteria:

Male or female having any disability Any recent illness or any injury

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04862988


Locations
Layout table for location information
Pakistan
Riphah International University
Faisalabad, Punjab, Pakistan, Pakistan, 38000
Sponsors and Collaborators
Riphah International University
Investigators
Layout table for investigator information
Study Chair: Muhammad Kashif Riphah International University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Riphah International University
ClinicalTrials.gov Identifier: NCT04862988    
Other Study ID Numbers: REC-FSD-00233
First Posted: April 28, 2021    Key Record Dates
Last Update Posted: September 14, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Riphah International University:
GPAQ
reliability,
Validity
Urdu